Information Library
Clinical and marketing materials - Flexible outsourcing
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
A Testimonial About Innovex Portugal
March 30, 2009
A testimonial about commercialization through Innovex. -
How to Keep All Your Licenses in Compliance
March 25, 2009
Our customer had a series of pharmaceutical and biological products that had been on the market in various countries for 10 years or more. They made a number of manufacturing improvements, and they needed to update their myriad licenses. -
Maneuvering a Drifting Project Back on Course
March 25, 2009
The NDA had been drifting within the FDA for years, and now it was subject to intense scrutiny by two agency reviewers. -
John Doyle, Dr. PH
March 25, 2009
John was president and a founder of Analytica International a global reimbursement, outcomes and market access consulting firm. He previously led the Oncology and Immunology Economics Research Group at Bristol-Myers Squibb. -
A New Gold Standard for Pricing
September 26, 2008
Dr. John Doyle, practice leader for market access at Quintiles Consulting, introduces the concept of a health economic balance sheet and evidence-based pricing for biopharmaceutical valuation.
Page 1 of 1 (5 items)